Synthesis of analogs of Hoechst 33258 designed for altered base and sequence recognition

Synthetic Communications

Volumn 30, Issue 5, 2000, Pages 923-939

  Singh, Ashok K ^a   Lown, J W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; 5 (4 METHYL 1 PIPERAZINYL) 2 (2' ACETOXYMETHYL 4',7' DIMETHOXY 5' BENZIMIDAZOLYL) 3H IMIDAZO[4,5 B]PYRIDINE; 5 (4 METHYL 1 PIPERAZINYL) 2 (2' ACETOXYMETHYL 4',7' DIMETHOXY 5' BENZIMIDAZOLYL)BENZIMIDAZOLE; 5 (4 METHYL 1 PIPERAZINYL) 2 (2' ETHOXYMETHYL 4',7' DIMETHOXY 5' BENZIMIDAZOLYL) 3H IMIDAZO[4,5 B]PYRIDINE; 5 (4 METHYL 1 PIPERAZINYL) 2 (2' ETHOXYMETHYL 4',7' DIMETHOXY 5' BENZIMIDAZOLYL)BENZIMIDAZOLE; 5 (4 METHYL 1 PIPERAZINYL) 2 (2' METHOXYMETHYL 4',7' DIMETHOXY 5' BENZIMIDAZOLYL) 3H IMIDAZO[4,5 B]PYRIDINE; 5 (4 METHYL 1 PIPERAZINYL) 2 (2' METHOXYMETHYL 4',7' DIMETHOXY 5' BENZIMIDAZOLYL)BENZIMIDAZOLE; ANTINEOPLASTIC AGENT; BENZIMIDAZOLE DERIVATIVE; DIAMINE DERIVATIVE; NITROBENZENE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; STRUCTURE ANALYSIS;

EID: 0034061772     PISSN: 00397911     EISSN: None     Source Type: Journal    
DOI: 10.1080/00397910008087106     Document Type: Article

References (21)

1. Harshman, K.D. and Dervan, P.B. Nucleic Acids Res., 1985, 13, 4825.
2. Gupta, R., Wang, H., Huang L and Lown, J.W. Anti-Cancer Drug Design, 1995, 10, 25.
3. Wang, H. Gupta, R. and Lown, J.W. Anti -Cancer Drug Design, 1994, 9, 153.
4. Sun, Q., Gatto, B., Yu, C., Liv, L.F. and La Voie, E.J. Bioorg. Med. Chem. Letters, 1994, 4, 2871.
5. Kumar, S., Joseoh, T., Singh, M.P., Bathini, Y. and Lown, J.W. J.Biomol. Struct. Dyn., 1992, 9, 853.
6. Bathini, Y., Rao, K.E., Shea, R.G. and Lown, J.W. Chem. Res. Toxicoi., 1990, 3, 268.
7. Pjura, P.E., Grzeskowiak, I., Dickerson, R.E. J. Mol. Biol., 1987, 797, 257.
8. Teng, M-K., Usman, N., Frederick, C-A., Wang, A. H-J. Nucleic Acids Res., 1988, 16, 2671.
9. Parkinson, J. A., Barber, J., Douglas, K.T., Rosamund, J. and Sharples, D. Biochemistry, 1990, 29, 10181.
10. Searle, M.S. and Embrey, K-J. Nucleic Acids Res., 1990, 78, 3753.
11. Fede, A., Labhardt, A., Bannwarth, W., Leupin, W. Biochemistry, 1991, 30, 11377.
12. Goodsell, D. and Dickerson, R.E. J. Med.Chem., 1986, 29, 727.
13. Bachur, N. R., Yu, F., Johnson, R., Hickey, R., Wu, Y. and Malkas, L. Mol. Pharmacol., 1992, 41, 993.
14. Bachur, N.R., Johnson, R., Yu, F., Hickey, R., Applegren, N. and Malkas, L. Mol. Phannacol, 1993, 44, 1064.
15. Guan, L., Zhao, R., and Lown, J.W. Biochem. Biophys. Res. Commun., 1997, 231, 94.
16. Soderlind, K-J., Gorodetsky, B., Singh, A.K., Bachur, N. R., Miller, G.G. and Lown, J.W. Anti-Cancer Drug Design , 1999, 14, 19.
17. Zhao R. and Lown, J.W. Heterocycl. Commun., 1998, 4, 11.
18. Singh, A.K. and Lown, J.W. Heterocycl. Commun., 1999, 5, 11.
19. Bathini, Y. and Lown J.W. Synth. Commun., 1990, 20, 955.
20. Phillips, M.A. J. Chem. Soc., 1928, 2393.
21. Singh , A.K. and Lown, J.W. Synth. Commun., 1998, 28, 4059.